维普期刊资源整合服务平台（V6.5）

64篇 您的检索式：作者名="Svane IM"

选中清除导出查看参考文献查看引证文献引用追踪共4页首页上一页第1页下一页末页 /4 跳转

	题名	作者	年代	出处	被引量
1	Dendrite cell-based cancer vaccines-clinical application显示文摘	Svane IM Bemtacn A Trepiakas R	2006	Ugeskr Laegnr2006，168，14：	1
2	Vaccination with p53-peptide-pulsed dendritic cells,of patients with advanced breast cancer:report from a Phase I study显示文摘	Svane IM Pedersen AE Johnsen HE		0，，：	1
3	Immunotherapy for meta- static colorectal cancer: present status and new options显示文摘	Ellebaek E Andersen MH Svane IM	2012	Scand J Gastroenterol2012，47，3：	1
4	The universal character of the tumor-associated antigen survivin显示文摘	Andersen MH Svane IM Becker JC	2007	Clin Cancer Res2007，13，20：	1
5	Characterization of monocyte-derived dendritic cells maturated with IFN-alpha显示文摘	Svane IM Nikolajsen K Walter MR	2006	Scand J Immunol2006，63，：	1
6	The universal character of the tumor-associated antigen survivin 显示文摘	Andersen MH Svane IM Becker JC	2007	Clin Cancer Res2007，13，20：	1
7	Immunotherapy formetastatic colorectal cancer:Present status and new options显示文摘	Ellebaek E Andersen MH Svane IM	2012	ScandJ Gastroenterol2012，47，3：	1
8	Silencing of the glucocorticoidinduced leucine zipper improves the immunogenicity of clinicalgrade dendritic cells显示文摘	Cathelin D Met Svane IM	2013	J Cytotherapy2013，15，6：	1
9	Immune response in patients with metastatic renal cell carcinoma treated with dendritic cells pulsed with tumor lysate显示文摘	Soleimani A Berntsen A Svane IM	2009	Scand J Immunol2009，70，5：	1
10	RhoC a new target for therapeutic vaccination against metastatic cancer 显示文摘	Wenandy L Sφrensen RB Svane IM	2008	Cancer Immunol Immunother2008，27，8：	1
11	The universal character of the tumor-associated antigen survivin显示文摘	Andersen MH Svane IM Beeker JC	2007	Clin Cancer Res2007，13，20：	1
12	The universal character of the tumor-associated antigen survivin 显示文摘	Andersen MH Svane IM Becker JC	2007	Clin Cancer Res2007，13，20：	1
13	HLA-B35-restricted immune responses against Survivin in cancer patients显示文摘	Becker JC Svane IM et a1	2004	Int J Cancer2004，108，6：	1
14	The universal character of the tumor-associated antigen survivin显示文摘	Andersen MH Svane IM Becker JC	2007	Clin Cancer Res2007，13，20：	1
15	Vaccination with p53 peptide-pulsed dendritic cells is associated with disease stabilization in patients with p53 expressing advanced breast cancer; monitoring of serum YKL-40 and IL-6 as response biomarkers 显示文摘	Svane IM Pedersen AE Johansen JS	2007	Cancer Immunol hnmunother2007，56，9：	1
16	Immunogenicity of Bcl-2 in cancer patients显示文摘	Andersen MH Svane IM Kvistborg P	2005	Blood2005，105，2：	1
17	Vaccination with p53 peptide-pulsed dendritic cells is associated with disease stabilization in patients with p53 expressing advanced breast cancer; monitoring of serum YKL-40 and IL-6 as response biomarkers显示文摘	Svane IM Pedersen AE Johansen JS	2007	Cancer Immunol Immunother2007，56，9：	1
18	Vaccination with p53 peptide-pulsed dendritic cells is associated with disease stabilization in patients with p53 expressing advanced breast cancer:monitoring of serum YKL-40 and IL-6 as response biomarkers显示文摘	Svane IM Pedersen AE Johansen JS Johnsen HE Nielsen D Kamby C	2007	Cancer Immunol Immunother2007，56，9：	1
19	CD8 T-cell responses against cyclin B1 in breast cancer patients with tumors overexpres-sing p53显示文摘	Srensen RB Andersen RS Svane IM	2009	Clin Cancer Res2009，15，5：	1
20	Vaccination with p53-peptide-pulsed dendritic cells of patients with advanced breast cancer: report from a phase I study显示文摘	Svane IM Pedersen AE Johnsen HE	2004	Cancer Immunol Immunother2004，53，7：	1

返回顶部每页显示：

共4页首页上一页第1页下一页末页 /4 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示